The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProteome Share News (PRM)

Share Price Information for Proteome (PRM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.51
Bid: 3.02
Ask: 4.00
Change: 0.00 (0.00%)
Spread: 0.98 (32.45%)
Open: 3.51
High: 0.00
Low: 0.00
Prev. Close: 3.51
PRM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Proteome Sciences Outlook Positive; Sales Remain Stable In Five Months

Fri, 26th Jun 2020 14:52

(Alliance News) - Proteome Sciences PLC on Friday reported stable sales in the first five months of 2020 and said it expects "this positive trend" to continue for the reminder of the year.

Ahead of its annual general meeting, the science research company reported continued progress throughout the business after delivering profit after tax in 2019.

Proteome Sciences said it has experienced good growth in services revenue and sales of both TMT and TMTpro have remained stable over the first five months of 2020.

"Despite the challenges of the Covid-19 pandemic, our dedicated staff have ensured we remained fully operational and have delivered 11 projects carried over from 2019 for which we already had samples," said Chair Christopher Pearce.

A further 10 projects are ongoing and new orders are also being generated, Proteome Sciences noted.

"We expect these positive trends to continue through the rest of the year," added Pearce.

AIM-listed Proteome Sciences shares were trading 6.5% lower in London on Friday afternoon at 3.50 pence each.

By Evelina Grecenko; evelinagrecenko@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
8 Jul 2014 11:22

REPEAT: UK MIDDAY BRIEFING: M&S Online Sales Slump On Website Move

Read more
8 Jul 2014 11:19

UK MIDDAY BRIEFING: M&S Sales Slump On Website Move

Read more
8 Jul 2014 10:42

UK WINNERS & LOSERS: Airline Stocks Nosedive On Air France-KLM Warning

Read more
8 Jul 2014 08:45

UPDATE 1-Study paves way for simple blood test to predict Alzheimer's

* Fatal brain-wasting disease has no effective treatments * Experts say drug failures may be due to late trials * Predictive test could find people before disease sets in * Shares in Proteome Sciences, involved in work, jump 12 pct (Adds Proteome Sciences stock move) By

Read more
8 Jul 2014 08:26

Proteome Sciences Publishes Study For Alzheimer's Blood Test

Read more
29 May 2014 10:22

Proteome Sciences Confident For Revenue Growth As Loss Narrows

LONDON (Alliance News) - Proteome Sciences PLC Thursday expressed confidence for continued fast revenue growth for the "forseeable future", as it posted a narrowed pretax loss for 2013, driven by strong sales of its Tandem Mass Tag reagents and growth in its biomarker assays. Proteome is en

Read more
27 Mar 2014 14:08

Proteome Says Study Using SysQuant Technology Demonstrates Its Potential

LONDON (Alliance News) - Proteome Sciences PLC said Thursday that a study using its SysQuant technology to address pancreatic cancer published in medical journal PLOS ONE demonstrated the potential of proteomics to improve the way that bespoke treatments can be made to match patients. Prote

Read more
28 Feb 2014 16:18

XP Power board members reduce holdings

XP Power's Chairman, Larry Tracey, on Thursday sold 75,000 shares in the power supply solutions manufacturer. Tracey, who has held his current role since April 2002, disposed of the shares at 1,755p a time, generating a total of £1.3m. Fellow board member James Peters, a Non-Executive Director, t

Read more
24 Feb 2014 10:48

Proteome Sciences To Raise GBP5 Million In Share Placing

LONDON (Alliance News) - Proteome Sciences PLC said Monday it has placed 17.9 million new shares on the market to raise GBP5 million before expenses, with new and existing investors, which it will use for additional working capital. The protein biomarker company said the shares were placed

Read more
7 Feb 2014 10:06

Proteome edges ahead after flagging rise in revenue

Biotech group Proteome Sciences edged ahead after it revealed it expects revenue for 2013 to show "a significant increase" over 2012 thanks to strong performance across its core activities. The firm is an expert in biomarkers, or biological markers, that can help predict the likelihood of cancer r

Read more
7 Feb 2014 09:08

Proteome Sciences Says 2013 Revenues To Be Significantly Up

LONDON (Alliance News) - Shares in Proteome Sciences PLC rose in early trading Friday, after the protein biomarker company said revenue for 2013 will be significantly higher than the prior year, driven by a strong performance from all its core activities. Proteome is engaged in research an

Read more
4 Dec 2013 10:39

Proteome Sciences unveils sales delays, shares fall

Biotechnology group Proteome Sciences is facing sales delays that will push revenue from some deals into next year, hitting its shares. Proteome, which carries out research into protein and peptide biomarkers to treat neurological conditions and other illnesses such as cancer, said the timing and r

Read more
20 Nov 2013 10:55

Proteome Sciences Says Study Using Its Workflows Shows New Protein Biomarkers For Liver Cancer

Read more
20 Nov 2013 07:52

AIM IN BRIEF: Rangers FC Appoints Graham Wallace As CEO

Read more
30 Sep 2013 09:26

Proteome Sciences Losses Widen Despite Revenue Growth; Signs USD2.1M Contract

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.